Eye Institute Annual Fall Symposium and Celebration of the Gary W. Abrams Lectureship - FRIDAY ONLY
The aim of this program is to provide a comprehensive update on a variety of ophthalmic diseases, placing an emphasis on meeting the current challenges in diagnosis and management. Current challenges involve the use of anti-vascular endothelial growth factor agents in age-related macular degeneration, development of new approaches to treating retinal degenerative diseases, optic neuritis, epiphora, prophylaxis of infection in ophthalmic surgery, and recognition of ocular toxicity. Clinical implementation of diagnostic imaging modalities such as optical coherence tomography and adaptive optics imaging will also be discussed.
Because of the rapidity with which advancements in ophthalmic imaging technology, surgical instrumentation, and pharmacologic therapies have occurred, rational integration of these modalities into clinical practice has been challenging. To meet this challenge, clinicians must acquire an understanding of both the basic mechanisms underlying such modalities and the means by which they can be applied in a rational fashion to patient care. In addition, understanding of the underlying disease states must be acquired. These challenges remain for numerous subspecialty areas in ophthalmology.
Please note: a $2.60 processing fee will be assessed for all registrations.
There is a $50 cancellation fee.
This educational activity is aimed at practicing ophthalmologists, subspecialty ophthalmologists, optometrists, ophthalmology residents and fellows, medical students, vision scientists, photographers, ophthalmic nurses and technicians.
- Demonstrate a practical approach to the pharmacotherapy of age-related macular degeneration, ocular infection, and other retinal diseases
- Identify and illustrate a rational implementation of optical coherence tomography and other imaging modalities in ophthalmic care
- Describe key technological developments in area of vitreoretinal surgery and disease management
Dennis P. Han, MD
Jack A. & Elaine Klieger Professor of Ophthalmology
All persons in control of content have NO relevant financial relationships to disclose with the exception of the following persons:
William Wirostko, MD
David Weinberg, MD
Kimberly Stepien, MD
Gary Abrams, MD, FARVO
Alcon Research Institute
Retrosense Therapeutics, Inc
H. Culver Boldt, MD
Raymond Iezzi, MD, MS
H. Richard McDonald, MD
Odette Houghton, MD
Jane Werner, MD
Glen Jaffe, MD
Thomas Connor, Jr., MD
Consultant / Speaker
Dennis P. Han, MD
Flow One Healthcare
In accordance with the ACCME® Standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved
- 2.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 2.00 Hours of ParticipationHours of Participation credit.